COVID-19 Evidence Accelerator: A parallel analysis to describe the use of Hydroxychloroquine with or without Azithromycin among hospitalized COVID-19 patients.

Saved in:
Bibliographic Details
Title: COVID-19 Evidence Accelerator: A parallel analysis to describe the use of Hydroxychloroquine with or without Azithromycin among hospitalized COVID-19 patients.
Authors: Stewart M; Friends of Cancer Research, Washington, District of Columbia, United States of America., Rodriguez-Watson C; Reagan-Udall Foundation for the FDA, Washington, District of Columbia, United States of America., Albayrak A; Health Catalyst, Salt Lake City, Utah, United States of America., Asubonteng J; Gilead Science, Inc. Foster City, California, United States of America., Belli A; COTA, Inc., Boston, Massachusetts, United States of America., Brown T; Syapse, San Francisco, California, United States of America., Cho K; Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, Massachusetts, United States of America.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America., Das R; Dascena, Oakland, California, United States of America., Eldridge E; Health Catalyst, Salt Lake City, Utah, United States of America., Gatto N; Aetion, New York, New York, United States of America., Gelman A; Health Catalyst, Salt Lake City, Utah, United States of America., Gerlovin H; Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, Massachusetts, United States of America., Goldberg SL; Division of Outcomes and Value Research, John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States of America., Hansen E; COTA, Inc., Boston, Massachusetts, United States of America., Hirsch J; Syapse, San Francisco, California, United States of America., Ho YL; Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, Massachusetts, United States of America., Ip A; Division of Outcomes and Value Research, John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States of America., Izano M; Syapse, San Francisco, California, United States of America., Jones J; Health Catalyst, Salt Lake City, Utah, United States of America., Justice AC; VA Connecticut Healthcare System, West Haven, Connecticut, United States of America.; Yale University Schools of Medicine and Public Health, New Haven, Connecticut, United States of America., Klesh R; HealthVerity, Philadelphia, Pennsylvania, United States of America., Kuranz S; TriNetX, Cambridge, Massachusetts, United States of America., Lam C; Dascena, Oakland, California, United States of America., Mao Q; Dascena, Oakland, California, United States of America., Mataraso S; Dascena, Oakland, California, United States of America., Mera R; Gilead Science, Inc. Foster City, California, United States of America., Posner DC; Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, Massachusetts, United States of America., Rassen JA; Aetion, New York, New York, United States of America., Siefkas A; Dascena, Oakland, California, United States of America., Schrag A; Syapse, San Francisco, California, United States of America., Tourassi G; National Center for Computational Sciences Oak Ridge National Laboratory, Oak Ridge, Tennessee, United States of America., Weckstein A; Aetion, New York, New York, United States of America., Wolf F; Syapse, San Francisco, California, United States of America., Bhat A; Reagan-Udall Foundation for the FDA, Washington, District of Columbia, United States of America., Winckler S; Reagan-Udall Foundation for the FDA, Washington, District of Columbia, United States of America., Sigal EV; Friends of Cancer Research, Washington, District of Columbia, United States of America.; Reagan-Udall Foundation for the FDA, Washington, District of Columbia, United States of America., Allen J; Friends of Cancer Research, Washington, District of Columbia, United States of America.
Source: PloS one [PLoS One] 2021 Mar 17; Vol. 16 (3), pp. e0248128. Date of Electronic Publication: 2021 Mar 17 (Print Publication: 2021).
Publication Type: Journal Article
Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1932-6203
DOI:10.1371/journal.pone.0248128